作者: Tom Powles , Shanthini M. Crusz
DOI: 10.1200/EDBOOK_AM.2013.33.E172
关键词:
摘要: There is a strong rationale for sequencing targeted therapy in metastatic clear cell renal cancer. However the timing of switch and best agent to remains unclear. Randomized data ...